|
|
|
2011 SABPA Biopharma Conference (6/4 San Diego) |
|
2011/5/4 15:30:40 | 浏览:2961 | 评论:1 |
|
|
|
San Diego Bio-Pharma Conference is an annual event aimed at promoting life sciences organizations with emphasis on growth, technology and innovation. It is dedicated to educating and empowering the biotech and pharmaceutical community in Southern California. The theme of this year’s conference is Moving Forward.
Date :8:00 am – 5:00 pm, June 4th, 2011, Location :Hilton, San Diego/Del Mar(15575 Jimmy Durante Blvd, Del Mar, CA92014) Website :http://www.sdbiopharma.org/2011/bio-index.htm Registration:https://www.123signup.com/event?id=vprmg $30 per person for early birds registration(valid until May 27); $50 for regular registration(valid between May 28 and June 1); $80 for onsite registration(June 4); $10 off any fees mentioned above for students and postdocs
Organizers : Sino-American Biomedical & Pharmaceutical Professionals Association(SABPA) San Diego Chinese American Association(SDCAA)
Program:
- 8:00 am - 5:00 pm
- 8:00 am - 8:45 am
- Continental Breakfast & Registration
- 8:45 am - 9:00 am
- 9:00 am - 10:00 am
- Session I. New Frontiers in Life Science Research and Development
- Jeffrey Kelly, Professor, The Scripps Research Institute
- Don Jones, Vice President, Business Development for Health & Life Sciences, Qualcomm
- 10:00 am - 10:30 am
- 10:30 pm - 12:00 pm
- Session II(Plenary Discussion). Sustainable Biotech Growth in San Diego
- Joe Panetta, President and CEO, BIOCOM(Moderator)
- Magda Marquet, Co-Chairman & Founder, Althea Technologies; Founder and co-Chair of Althea Dx
- Brent Jacobs, Senior Director, Cushman & Wakefield
- David Webb, Vice President, Research & Site Director, San Diego, Celgene
- 12:00 pm - 1:30 pm
- 1:30 pm - 2:00 pm
- San Diego Bio-Pharma Achievement Award
- Award Recipient:Paul Schimmel, Professor, The Scripps Research Institute
- 2:00 pm - 3:00 pm
- Session III. Drug Discovery in the current challenging climate
- James Merson, SVP, Vaccine Research West at Pfizer BioTherapeutics
- Rich Heyman, CEO, Aragon Pharmaceuticals
- 3:00 pm - 3:30 pm
- 3:30 pm - 4:45 pm
- Session IV(Plenary Discussion). Pharmaceutical Research and Development in China
- Greg Scott, President and Founder, ChinaBio(Moderator)
- Xifu Liu, President, Zensun USA, Inc
- Bill Piu Chan, President and CEO, Wincon Theracells Biotechnologies
- 4:45 pm - 4:50 pm
|
|
|
|